COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,082 Articles (22,658 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 260: Articles 2591-2600  | Next

Effective assessment of CD4+ T cell Immunodominance patterns: impact of antigen processing and HLA restriction
Alvaro-Benito, M., Abualrous, E. T., Lingel, H., Meltendorf, S., Holzapfel, J., Sticht, J., Kuropka, B., Clementi, C., Kuppler, F., Brunner-Weinzierl, M. C., Freund, C.
10.1101/2024.01.10.574975 — Posted: 2024-01-10
Neuropsychiatric sequelae in an experimental model of post-COVID syndrome in mice
Pimenta, J. C., Beltrami, V. A., Oliveira, B. D. S., Queiroz-Junior, C. M., Barsalini, J., Teixeira, D. C., Souza-Costa, L. P., Lima, A. L. D., Machado, C. A., Parreira, B. Z. S. G., Santos, F. R. d. S., Costa, P. A. C., Lacerda, L. D. S. B., Goncalves, M. R., Chaves, I. d. M., Couto, M. G. G., Costa, V. R. d. M., Nobrega, N. R. C., Silva, B. L., Fonseca, T., Resende, F., Wnuk, N. T., Umezu, H. L., Campolina-Silva, G., Andrade, A. C., Santana de Aguiar, R., Costa, G. M. J., Guimaraes, P. P., Silva, G. S. F., Vieira, L. B., Pinho, V., Teixeira, A. L., Teixeira, M. M., Miranda, A. S., Costa, V. V.
10.1101/2024.01.10.575003 — Posted: 2024-01-10
Immunological imprinting shapes the specificity of human antibody responses against SARS-CoV-2 variants
Johnston, T. S., Li, S. H., Painter, M. M., Atkinson, R. K., Douek, N. R., Reeg, D. B., Doueck, D. C., Wherry, E. J., Hensley, S. E.
10.1101/2024.01.08.24301002 — Posted: 2024-01-09
Durability of protection from original monovalent and bivalent COVID-19 vaccines against COVID-19-associated hospitalization and severe in-hospital outcomes among adults in the United States -- September 2022-August 2023
DeCuir, J., Surie, D., Zhu, Y., Lauring, A. S., Gaglani, M., McNeal, T., Ghamande, S., Peltan, I. D., Brown, S. M., Ginde, A. A., Steinwand, A., Mohr, N. M., Gibbs, K. W., Hager, D. N., Ali, H., Frosch, A., Gong, M. N., Mohamed, A., Johnson, N. J., Srinivasan, V., Steingrub, J. S., Khan, A., Busse, L. W., Duggal, A., Wilson, J. G., Qadir, N., Chang, S. Y., Mallow, C., Kwon, J. H., Exline, M. C., Shapiro, N. I., Columbus, C., Vaughn, I. A., Ramesh, M. S., Safdar, B., Mosier, J. M., Casey, J. D., Talbot, H. K., Rice, T. W., Halasa, N., Chappell, J. D., Grijalva, C. G., Baughman, A., Womack, K. N
10.1101/2024.01.07.24300910 — Posted: 2024-01-09
Estimation of SARS-CoV-2 fitness gains from genomic surveillance data without prior lineage classification
Donker, T., Papathanassopoulos, A., Ghosh, H., Kociurzynski, R., Felder, M., Grundmann, H., Reuter, S.
10.1101/2024.01.08.24300976 — Posted: 2024-01-09
Symptoms of children and adolescents infected with SARS-CoV-2 variants alpha, delta or omicron
Schulze, H., Bayer, W.
10.1101/2024.01.07.23300006 — Posted: 2024-01-09
How executive control and emotional reactivity influence coping strategies in psychiatric patients during the COVID-19 pandemic
Kist, J. D., Schlüter, L., Duyser, F., Mulders, P. C. R., Vrijsen, J. N., Collard, R. M., van Eijndhoven, P., Tendolkar, I.
10.1101/2024.01.08.24300980 — Posted: 2024-01-09
Preferential apical infection of intestinal cell monolayers by SARS-CoV-2 is associated with damage to cellular barrier integrity: Implications for the physiopathology of COVID-19
Clemence, G., Jeffrey, A., Jonatane, A., Mege, J.-L., Omar Osman, I., Devaux, C. A.
10.1101/2024.01.08.574642 — Posted: 2024-01-09
Efficient overexpression and purification of SARS-CoV-2 Nucleocapsid proteins in Escherichia coli
Brudenell, E. L., Pohare, M. B., Zafred, D., Phipps, J., Hornsby, H. R., Darby, J., Dai, J., Liggett, E., Cain, K., Barran, P. E., de Silva, T. I., Sayers, J. R.
10.1101/2024.01.08.574531 — Posted: 2024-01-09
Human bronchopulmonary disposition and plasma pharmacokinetics of oral bemnifosbuvir (AT-527), an experimental guanosine nucleotide prodrug for COVID-19
Zhou, X.-J., Horga, A., Puri, A., Winchester, L., Montrond, M., Pietropaolo, K., Belanger, B., Fletcher, C. V., Hammond, J.
10.1101/2024.01.03.24300783 — Posted: 2024-01-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).